Related Experiment Video
Updated: Jun 8, 2025

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
Published on: October 27, 2023
Mendelian randomization studies in ankylosing spondylitis: A systematic review
Jiangnan Wei1, Xiuyuan Zhu1, Jiaxian Wang1
1Department of Nursing, Zhuhai Campus of Zunyi Medical University, Zhuhai, Guangdong, China.
Introduction:
Previous research has revealed connections between ankylosing spondylitis (AS) and comorbid conditions. However, observational studies frequently encounter difficulties in establishing definitive causal links between potential risk factors and AS. In contrast, Mendelian randomization (MR) offers a more robust approach to exploring causality by leveraging the random allocation of alleles at birth, thereby minimizing confounding factors.
Methods:
The PubMed, Web of Science, and Cochrane databases were searched for MR studies related to AS with a time frame of database creation to May 2024. Information on authors, exposures, outcomes, data sources, SNPs, MR analysis methods, ORs (95% CIs), and p-values was extracted. Quality assessment was performed using the Critical Appraisal Skills Program (CASP) checklist.
Results:
We systematically reviewed 42 MR studies in AS. Health behaviors, comorbidities, and serum markers were involved. Overall, physical activity, inflammatory bowel disease, and specific intestinal flora with serum markers as exposures were causally associated with AS, which leads to an increased risk with several comorbidities.
Conclusions:
MR is a powerful tool for assessing causal relationships between risk factors and outcomes. Specific intestinal flora and inflammatory bowel disease appear to be uncontroversial risk factors that increase the risk of AS. Reliable and robust MR findings may provide a more comprehensive health management strategy for patients with AS.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway

